Latest News
Posted On: Sep 27, 2022
|
THE UNITED REPUBLIC OF TANZANIA MINISTRY OF HEALTH TANZANIA MEDICINES AND MEDICAL DEVICES AUTHORITY |
|
ISO 9001: 2015: CERTIFIED
PUBLIC NOTICE
25th September, 2022
Submission of Appointment of Qualified Person for PharmacoVigilance (QPPV)
- Tanzania Medicines and Medical Devices Authority (TMDA) wishes to inform our esteemed customers that in line with Section 8(1), 11, 12 and 24 of the Tanzania Medicines and Medical Devices (Pharmacovigilance) Regulations, 2018, Market Authorization Holders (MAHs) are required to establish a functioning pharmacovigilance system and appoint a Qualified Person for PharmacoVigilance (QPPV) to oversee it.
- The system will be used for receiving, handling, evaluating and reporting Adverse Drug Reactions (ADRs) of their products.
- In light of the above, you are required to submit appointment letters, curricula vitae as well as copies of qualification certificates of the appointed personnel as QPPV. Proof of initial and continued training as QPPV should also be submitted.
- The requested documents should be sent to the Authority by e-mail through info@tmda.go.tz or submitted physically to the address below, not later than two weeks from the date of this notice.
- We thank you for your continued cooperation.
Director General,
Tanzania Medicines and Medical Devices Authority (TMDA),
Swaswa Road,
P. O. Box 1253, Dodoma Or
P. O. Box 77150, Dar es Salaam
Phone: +255 22 2452108/2450512/2450751
Fax: +255 22 2450793